| Literature DB >> 30065298 |
Alessia Castagnino1, Antonio Castro-Castro1, Marie Irondelle1,2, Alan Guichard1, Catalina Lodillinsky1,3,4, Laetitia Fuhrmann5, Sophie Vacher6, Sonia Agüera-González1, Anna Zagryazhskaya-Masson1, Maryse Romao7, Carole El Kesrouani5, Angelika A Noegel8, Thierry Dubois9, Graça Raposo7, James E Bear10, Christoph S Clemen8,11, Anne Vincent-Salomon5, Ivan Bièche6,12, Philippe Chavrier13.
Abstract
Membrane type 1-matrix metalloproteinase (MT1-MMP), a membrane-tethered protease, is key for matrix breakdown during cancer invasion and metastasis. Assembly of branched actin networks by the Arp2/3 complex is required for MT1-MMP traffic and formation of matrix-degradative invadopodia. Contrasting with the well-established role of actin filament branching factor cortactin in invadopodia function during cancer cell invasion, the contribution of coronin-family debranching factors to invadopodia-based matrix remodeling is not known. Here, we investigated the contribution of coronin 1C to the invasive potential of breast cancer cells. We report that expression of coronin 1C is elevated in invasive human breast cancers, correlates positively with MT1-MMP expression in relation with increased metastatic risk and is a new independent prognostic factor in breast cancer. We provide evidence that, akin to cortactin, coronin 1C is required for invadopodia formation and matrix degradation by breast cancer cells lines and for 3D collagen invasion by multicellular spheroids. Using intravital imaging of orthotopic human breast tumor xenografts, we find that coronin 1C accumulates in structures forming in association with collagen fibrils in the tumor microenvironment. Moreover, we establish the role of coronin 1C in the regulation of positioning and trafficking of MT1-MMP-positive endolysosomes. These results identify coronin 1C as a novel player of the multi-faceted mechanism responsible for invadopodia formation, MT1-MMP surface exposure and invasiveness in breast cancer cells.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30065298 DOI: 10.1038/s41388-018-0422-x
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867